Shandong Boan Biotechnology Co., Ltd. reported no changes in its share capital structure for the month ended 30 April 2026. Authorised/registered and issued H-shares both closed the month unchanged at 622.33 million shares with a par value of RMB 1.00 each, keeping total registered capital at RMB 622.33 million.

The company held no treasury shares during the period, and no share options, warrants, convertibles or other equity instruments were outstanding or exercised.

Directors confirmed that the public float remained above the minimum 18.14 percent threshold specified under the Stock Exchange waiver—satisfying Main Board Rule 13.32D(1).

All statutory confirmations were filed by Director Jiang Hua on 07 May 2026, stating full compliance with Hong Kong Listing Rules and other regulatory requirements.